A new paper in Urology suggests that combination of data from multiparametric magnetic resonance imaging (mpMRI) with traditional risk factors (Gleason score, clinical stage, PSA level, etc.) may be able to improve identification of men at risk for clinically significant prostate cancer at time of diagnosis. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk, Treatment | Tagged: criteria, Epsetin, mpMRI, MRI, multiparametric, risk | Leave a comment »
A recent video-discussion on the OncLive web site addresses the complexities in the evolution of application of multiparametric MRI scanning and MRI/TRUS fusion biopsies in the diagnosis of early stage prostate cancers. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: biopsy, fusion, MRI, multiparametric, TRUS | 2 Comments »
An article in The Daily Telegraph in the UK this morning addresses a variety of issues related to the difficulties associated with the use of TRUS-guided prostate biopsy to diagnose localized and locally advanced prostate cancer. … READ MORE …
Filed under: Diagnosis, Risk | Tagged: accuracy, biopsy, Diagnosis, mpMRI, MRI, multiparametric, scan | 1 Comment »
A new review article in Oncology discusses the potential of multiparametric magnetic resonance imaging (mpMRI) in the diagnosis and management of prostate cancer, and will be useful reading for many advocates and support group leaders. … READ MORE …
Filed under: Diagnosis, Living with Prostate Cancer, Management, Risk | Tagged: Diagnosis, imaging, MRI, multiparametric, prognosis | 3 Comments »
THE "NEW" PROSTATE CANCER INFOLINK 